C103H137F9N28O7 — CID 167623941
3-[3-[[5-cyclopropyl-2-[2-ethyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one;4-[3-[[2-[2-cyclopropyl-4-(4-methylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]morpholin-3-one;(3S)-1-[3-ethyl-4-[[4-[3-(2-oxopiperidin-1-yl)propylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-3-carbonitrile;3-[3-[[2-(2-ethyl-4-piperazin-1-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one (PubChem CID 167623941) has the molecular formula C103H137F9N28O7 and a molecular weight of 2050.40 g/mol. Its IUPAC name is 3-[3-[[5-cyclopropyl-2-[2-ethyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one;4-[3-[[2-[2-cyclopropyl-4-(4-methylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]morpholin-3-one;(3S)-1-[3-ethyl-4-[[4-[3-(2-oxopiperidin-1-yl)propylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-3-carbonitrile;3-[3-[[2-(2-ethyl-4-piperazin-1-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one.
| Compound Name | 3-[3-[[5-cyclopropyl-2-[2-ethyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one;4-[3-[[2-[2-cyclopropyl-4-(4-methylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]morpholin-3-one;(3S)-1-[3-ethyl-4-[[4-[3-(2-oxopiperidin-1-yl)propylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-3-carbonitrile;3-[3-[[2-(2-ethyl-4-piperazin-1-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one |
|---|---|
| PubChem CID | 167623941 |
| Molecular Formula | C103H137F9N28O7 |
| Molecular Weight | 2050.40 g/mol |
| Exact Mass | 2049.11 |
| IUPAC Name | 3-[3-[[5-cyclopropyl-2-[2-ethyl-4-(4-methylpiperazin-1-yl)anilino]pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one;4-[3-[[2-[2-cyclopropyl-4-(4-methylpiperazin-1-yl)anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]morpholin-3-one;(3S)-1-[3-ethyl-4-[[4-[3-(2-oxopiperidin-1-yl)propylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]phenyl]pyrrolidine-3-carbonitrile;3-[3-[[2-(2-ethyl-4-piperazin-1-ylanilino)-5-(trifluoromethyl)pyrimidin-4-yl]amino]propyl]-1,3-oxazinan-2-one |
| SMILES | CCc1cc(N2CCN(C)CC2)ccc1Nc1ncc(C2CC2)c(NCCCN2CCCOC2=O)n1.CCc1cc(N2CCNCC2)ccc1Nc1ncc(C(F)(F)F)c(NCCCN2CCCOC2=O)n1.CCc1cc(N2CC[C@H](C#N)C2)ccc1Nc1ncc(C(F)(F)F)c(NCCCN2CCCCC2=O)n1.CN1CCN(c2ccc(Nc3ncc(C(F)(F)F)c(NCCCN4CCOCC4=O)n3)c(C3CC3)c2)CC1 |
| InChI | InChI=1S/C27H39N7O2.C26H34F3N7O2.C26H32F3N7O.C24H32F3N7O2/c1-3-20-18-22(33-15-13-32(2)14-16-33)8-9-24(20)30-26-29-19-23(21-6-7-21)25(31-26)28-10-4-11-34-12-5-17-36-27(34)35;1-34-9-11-35(12-10-34)19-5-6-22(20(15-19)18-3-4-18)32-25-31-16-21(26(27,28)29)24(33-25)30-7-2-8-36-13-14-38-17-23(36)37;1-2-19-14-20(36-13-9-18(15-30)17-36)7-8-22(19)33-25-32-16-21(26(27,28)29)24(34-25)31-10-5-12-35-11-4-3-6-23(35)37;1-2-17-15-18(33-12-8-28-9-13-33)5-6-20(17)31-22-30-16-19(24(25,26)27)21(32-22)29-7-3-10-34-11-4-14-36-23(34)35/h8-9,18-19,21H,3-7,10-17H2,1-2H3,(H2,28,29,30,31);5-6,15-16,18H,2-4,7-14,17H2,1H3,(H2,30,31,32,33);7-8,14,16,18H,2-6,9-13,17H2,1H3,(H2,31,32,33,34);5-6,15-16,28H,2-4,7-14H2,1H3,(H2,29,30,31,32)/t;;18-;/m..1./s1 |
| InChIKey | MVBOGCVVCAAOBU-WGLOWRSCSA-N |
| XLogP | 16.41 |
| TPSA | 363.55 Ų |
| H-Bond Donors | 9 |
| H-Bond Acceptors | 31 |
| Rotatable Bonds | 37 |
| Heavy Atoms | 147 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2050.40 |
| LogP ≤ 5 | 16.41 |
| H-Bond Donors ≤ 5 | 9 |
| H-Bond Acceptors ≤ 10 | 31 |
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'} |
|---|